l e t t e r s
Palmoplantar keratodermas (PPKs) are a group of disorders that are diagnostically and therapeutically problematic in dermatogenetics [1] [2] [3] . Punctate PPKs are characterized by circumscribed hyperkeratotic lesions on the palms and soles with considerable heterogeneity. In 18 families with autosomal dominant punctate PPK, we report heterozygous loss-of-function mutations in AAGAB, encoding a-and g-adaptin-binding protein p34, located at a previously linked locus at 15q22. a-and g-adaptin-binding protein p34, a cytosolic protein with a Rab-like GTPase domain, was shown to bind both clathrin adaptor protein complexes, indicating a role in membrane trafficking. Ultrastructurally, lesional epidermis showed abnormalities in intracellular vesicle biology. Immunohistochemistry showed hyperproliferation within the punctate lesions. Knockdown of AAGAB in keratinocytes led to increased cell division, which was linked to greatly elevated epidermal growth factor receptor (EGFR) protein expression and tyrosine phosphorylation. We hypothesize that p34 deficiency may impair endocytic recycling of growth factor receptors such as EGFR, leading to increased signaling and cellular proliferation.
Palmoplantar keratoderma (MIM 148600) describes a group of hereditary skin disorders characterized by thickening (hyperkeratosis) of the epidermis of the palms and soles 1 . Historically, PPKs have been classified according to the pattern of lesions (diffuse, focal, punctate and striate), as well as by histopathological changes (epidermolytic, non-epidermolytic and porokeratotic). Molecular genetics now allows for improved classification and diagnosis and for personalized approaches to treatment. Three distinct types of inherited punctate PPK are recognized by Online Mendelian Inheritance in Man (OMIM) 2 : PPKP1 (also known as the Buschke-Fischer-Brauer type; MIM 148600), for which the associated locus mapped to 15q22 (refs. 4-6) ; PPKP2 (porokeratotic type; MIM 175860), for which no locus has been mapped yet; and PPKP3 (also known as acrokeratoelastoidosis; MIM 101850), for which preliminary linkage suggests a possible associated locus at 2p25-p12 (ref. 7 ). An additional disease-associated locus was identified at 8q24.13-8q24.21 in two Chinese families whose phenotypes resemble PPKP1 clinically and histologically 8 . Here we studied a collection of 18 kindreds with PPKP1 from Scotland, Ireland, Japan and Tunisia, 11 of whom had a family history consistent with autosomal dominant inheritance (Supplementary Fig. 1 ). In our PPKP1 case collection, there was considerable phenotypic variation ( Fig. 1) . In all families, onset was typically during the first to second decade of life, with the appearance of small circumscribed lesions on the palms and soles. These lesions consistently increased in number with advancing age and coalesced later to form larger lesions. In some families, lesions remained subtle (Fig. 1a,b) , whereas the phenotype in other families, resembling human papilloma virus (HPV)-induced papilloma-like lesions, was much more severe, painful and debilitating (Fig. 1c,d) . Histology of lesional palmar epidermis from three unrelated kindreds (families 1, l e t t e r s 11 and 15) all showed very similar findings of a well-defined central epidermal depression associated with hypergranulosis and a prominent layer of overlying orthokeratosis (Fig. 1e) . Immunohistochemical staining for the cell proliferation marker Ki67 showed continuous staining of the basal cell (proliferative) compartment of the epidermis beneath the hyperkeratotic lesions (Fig. 1f) , indicative of a hyperproliferative form of hyperkeratosis rather than a retention hyperkeratosis due to defective desquamation.
Microsatellite linkage to the previously reported 15q22 locus was observed in a large Tunisian kindred originating from Saudi Arabia (Supplementary Fig. 2) , with a maximum two-point logarithm of odds (LOD) score of 8.18 at recombination frequency (θ) = 0 obtained for D15S983 (Supplementary Table 1 ). The family was reported previously 9 . A 6.24-Mb key interval containing 80 RefSeq genes was defined by visible recombination with markers D15S993 (proximal) and D15S977 (distal). This locus overlaps the previously reported intervals associated with PPKP1 (Supplementary Table 2 ). In parallel, the proband in family 1 (of Scottish ancestry) was subjected to wholeexome sequencing. Of the 28,513 SNPs identified, we elected to concentrate on loss-of-function variants located within the key interval defined by our linkage data and that previously reported. Of 106 unique stop-gain SNPs in the exome data set, only 3 SNPs, all heterozygous in the proband, were located on chromosome 15 (Supplementary Table 3 ). Two were located well outside the interval, including a known SNP, rs57809907, in DYX1C1, c.1617C>T, predicted to cause a p.Glu417* alteration, and a second previously unreported variant of unknown consequence in GABRG3, c.1316T>A, predicted to cause a p.Leu439* alteration. The remaining variant, c.481C>T in AAGAB, predicted to cause a p.Arg161* alteration (mRNA, NM_024666; protein, NP_078942), fell within our linkage interval and that initially reported 5 but was just outside the interval reported in a Chinese kindred 6 . This variant was absent from current dbSNP and 1000 Genomes Project data sets (1 June 2012). The mutation was confirmed by conventional sequencing and cosegregated with the PPKP1 phenotype in family 1 ( Supplementary Fig. 3a,b) . By conventional sequencing, a second loss-of-function mutation, c.346_347delAG, was identified and found to fully cosegregate with disease in the linked kindred and two additional Tunisian families ( Supplementary  Fig. 3c,d) . Sequencing of the remaining 16 families identified a total of 8 mutations in AAGAB (2 nonsense, 5 frameshift and 1 splice-site mutation, as detailed in Supplementary Table 4) . AAGAB, consisting of ten exons spanning 53,708 bp of genomic DNA, encodes α-and γ-adaptinbinding protein p34, which was identified in a yeast two-hybrid screen using a subunit of the adapter protein (AP)-1 complex as bait 10 . The positions of the predicted alterations in relation to the protein organization of p34 are shown (Fig. 2) .
Conventional RT-PCR showed expression in palmoplantar epidermis comparable to that in abdominal skin (data not shown). By quantitative RT-PCR (qRT-PCR), we confirmed that AAGAB is expressed at broadly comparable levels in skin, HeLa cells, primary epidermal keratinocytes and the commonly used keratinocyte cell line, HaCaT 11 ( Fig. 3a) . Using qRT-PCR, we also showed that AAGAB message is very widely expressed across tissues, including npg l e t t e r s in the skin (Supplementary Fig. 4) . Two independent small interfering RNAs (siRNAs) were developed that resulted in almost complete reduction of the amount of p34 protein in HaCaT cells (Fig. 3b) .
Treatment of HaCaT cells with either of these potent siRNAs resulted in an approximately twofold increase in cell number over time compared to cells transfected with a negative control siRNA (Fig. 3c) , thus mirroring the high epidermal proliferation observed in lesional epidermis (Fig. 1f) .
The coating of clathrin-coated vesicles consists of clathrin and adaptor complexes, both of which have to be recruited to the appropriate membrane from the cytoplasm 12, 13 . The two most abundant types of adaptor protein complexes are AP-1, which is responsible for sorting proteins between the trans-Golgi network (TGN) and endosomes, and AP-2, which is responsible for sorting proteins at the plasma membrane. Both are heterotypic complexes, with AP-1 containing a γ-adaptin subunit and AP-2 containing an α-adaptin subunit. Although cDNA encoding p34 protein was the predominant species cloned from the original yeast two-hybrid screen 10 , difficulty in obtaining antibodies specific to the p34 protein meant that further biochemical confirmation of these protein-protein interactions were not presented. Here, using two independent antibodies to p34 that were made in house, we confirmed by immunoprecipitation combined with protein blotting that this protein indeed interacts with both AP-1 and AP-2 complexes in the cytosol (Fig. 4a) . Cytosolic localization was confirmed by immunocytochemistry using constructs encoding p34 fused to green fluorescent protein (GFP) at either the N or C terminus (Fig. 4b) , although fusion of GFP at the C terminus also led to some nuclear accumulation of the fusion protein.
Cell fractionation studies showed that p34 protein is found in the cytosol but not in the membrane or clathrin-coated vesicle fractions in HeLa cells (Fig. 4c) . Almost complete siRNA-mediated knockdown of AAGAB (Fig. 4d) did not lead to an obvious change in the plasma membrane or TGN localization of AP-2 or AP-1, respectively (Fig. 4e) . Neither AP-1 nor AP-2 colocalized with the N-or C-terminal GFP fusions of p34 (Supplementary Fig. 5 ). Essentially identical diffuse cytoplasmic localization data were obtained in the keratinocyte cell line HaCaT (data not shown). Overall, these data confirm that p34 is a cytosolic protein that binds to AP-1 and AP-2; however, p34 does not follow these protein complexes into their membraneassociated vesicle populations on intracellular membranes or at the plasma membrane, respectively. This finding is consistent with a possible chaperone function for p34, as previously suggested 10 . For example, p34 might either prevent soluble clathrin from assembling with soluble adaptor complexes in the cytosol, be involved in vesicle uncoating or aid recruitment of soluble adaptors to membranes 10 . Bioinformatics analysis identified a GTPase domain in p34, which is most closely related to the Rab superfamily of vesicular trafficking proteins ( Fig. 2 and Supplementary Fig. 6 ). It is not known whether this GTPase domain is functional. If this is the case, our finding may be indicative of a role for p34 in the active transport of cytosolic adaptor complexes rather than a more passive chaperone function 14 .
Ultrastructural analysis of lesional plantar skin showed mild acanthosis, a reduction in the granular cell layer and compact orthokeratosis (Supplementary Fig. 7) . In basal keratinocytes (Fig. 5) , there was a large increase in the number of small vesicles npg l e t t e r s close to the cell membrane and prominent dilatation of the Golgi apparatus in lesional epidermis compared to normal, control skin (Supplementary Fig. 7 ). These ultrastructural features are consistent with a defect in vesicle transport. We hypothesized that a mechanism whereby perturbation of vesicle trafficking could lead to increased epidermal proliferation might involve recycling of EGFR. EGFR is known to undergo rapid turnover in a process that requires a number of sorting steps, including clathrin-and AP-2-dependent endocytosis 15, 16 . Internalized ligand-bound EGFR is either shuttled to late endosomes/lysosomes for degradation or into recycling endosomes, where, after removal of the bound ligand and dephosphorylation, the receptor is returned to the plasma membrane via vesicle fusion. Knockdown of AAGAB in HaCaT cells led to a modest ~2.5-fold increase in EGFR mRNA levels relative to cells transfected with control siRNA, as determined by qRT-PCR (data not shown); however, the amount of total EGFR protein was >10-fold higher in protein blot analysis (Fig. 6a) , consistent with decreased EGFR turnover. Notably, phosphorylation of EGFR at Tyr992, indicating active EGFR signaling 17 , was increased by >20-fold in cells with AAGAB knockdown (Fig. 6b) . The regulation of EGFR signaling via clathrin-mediated endocytosis is a complex process mediated by Rab proteins 15 , dynamin 18 , AP-2 and the Grb2 adaptor protein that involves multiple mechanisms relating to post-translational modification of the receptor itself 19 . Disruption of EGFR endocytosis by double knockout of the Dnm1 and Dnm2 genes encoding the motor proteins dynamin-1 and dynamin-2, respectively, in mouse has been shown to result in decreased protein turnover with increased EGFR signaling 18 , very similar to what we observed with knockdown of AAGAB.
Here, using a combination of genetic linkage analysis and wholeexome sequencing, we have identified mutations in the AAGAB gene, encoding p34, that cause the autosomal dominant form of punctate PPK that was previously linked to 15q22 known as PPKP1 (MIM 148600) 5, 6, 9 . AP-2 is known to be involved in EGFR endocytosis 19 , and we confirmed here that p34 binds cytosolic AP-2 (Fig. 4) and show that p34 deficiency results in increased epidermal cell proliferation (Fig. 1f and Fig. 3) . Overall, p34 seems to have a hitherto unrecognized role in the control of cell division, possibly by contributing to normal endocytic recycling of receptor tyrosine kinases, such as EGFR 15, 16, 18, 19 . Other genes involved in intracellular vesicle trafficking have been linked to inherited skin diseases where hyperkeratosis and/or keratoderma form part of the phenotypic constellation. These genes include SNAP29 in cerebral dysgenesis, neuropathy, ichthyosis and keratoderma (CEDNIK) syndrome 20 and VPS33B in arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome 21 , both of which encode proteins required for vesicle membrane fusion in the epidermis and other tissues. Moreover, loss-of-function mutations in AP1S1, which encodes the small σ1A subunit of the AP-1 complex, have been shown to cause the recessive neurocutaneous disorder mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis and keratodermia (MEDNIK) 22 . Similarly, defects in multiple proteins involved in melanosome transport and fusion lead to the pigmentation disorder Griscelli syndrome 23 , and mutations in the gene encoding the AP-3 subunit protein β3A have been linked to Hermansky-Pudlak syndrome type 2, which consists of oculocutaneous albinism and other features 24 . Thus, mutations in a growing number of genes involved in vesicle transport have been linked to genetic skin disease, with or without extracutaneous phenotypes.
Disruption of EGFR signaling is a feature of neoplasia. There are anecdotal reports of cancer occurring in association with punctate PPK 25 ; however, without genetic testing, we cannot determine whether the AAGAB gene was involved in those cases. Although a few cases of cancer were reported in the larger families studied here, we did not observe cosegregation with the AAGAB mutations, and, therefore, any causal link between AAGAB mutations and cancer remains unproven.
It remains unclear why haploinsufficiency for this widely expressed gene leads to a phenotype limited to palm and sole epidermis, although this is not unusual in hereditary skin disease. For example, haploinsufficiency for the DSP or DSG1 genes encoding the desmosomal proteins desmoplakin and desmoglein-1, respectively (refs. 26,27) , both of which are structural proteins expressed throughout the epidermis, lead to striate palmoplantar keratoderma 28 . Another unanswered question relates to why the hyperkeratotic lesions are focal. These lesions are late in onset, appearing in the first or second decade of life, and increase in number with advancing age. This pattern of appearance might be explained by a 'second hit' mutation in AAGAB, and we therefore sequenced the gene using genomic DNA derived from microdissected lesional tissue from more than one affected individual. We found neither loss of heterozygosity nor a . Part of the blot was stained for β-actin for a loading control and to normalize EGFR quantification. Using the LI-COR Odyssey system, the observed upregulation of EGFR was found to be greater than tenfold.
(b) Knockdown of AAGAB with siRNA 1239 also leads to greatly increased phosphorylation of Tyr992 on the EGFR protein compared to transfection with NSC4. Using the LI-COR Odyssey system, the observed increase in phosphorylation of this residue was found to be >20-fold. We also attempted immunohistochemistry; however, neither the in-house nor commercially available antibody to p34 gave a signal on fixed abdominal tissue from a normal control. It is also possible that a second somatic mutation might occur in a gene other than AAGAB.
In conclusion, this study expands the molecular diagnostic repertoire for keratodermas and shows that the p34 protein, which is associated with AP-1 and AP-2, is involved in regulating epidermal cell division.
URLs. The Eastern Sequence and Informatics Hub (EASIH), http:// www.easih.ac.uk/; Pachyonychia Congenita Project, http://www. pachyonychia.org/.
METhods
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
1 h at room temperature and incubated overnight in a 1:1,000 dilution of antibody to phosphorylated EGFR (Tyr992; 2235, Cell Signaling Technology) in PBST containing 10 mM β-glycerophosphate at 4 °C. Blots were washed in three changes of PBST containing 10 mM β-glycerophosphate and incubated in a 1:1,000 dilution of HRP-conjugated goat secondary antibody to rabbit in PBST containing 10 mM β-glycerophosphate for 1 h at room temperature. After washing, blots were developed using enhanced chemiluminescence (ECL). For detection of β-actin, blots were blocked and antibodies were diluted in 5% non-fat milk in PBST under the same conditions as described above. A dilution of 1:10,000 was used for the antibody to actin (Sigma-Aldrich), and a 1:1,000 dilution was used for the secondary HRP-conjugated rabbit antibody to mouse. Quantification of protein bands on blots was performed using a LI-COR Odyssey infrared imaging system.
HeLa cell transfection.
Transfection of HeLa cells with siRNA was achieved with Oligofectamine (Invitrogen) following the manufacturer's instructions, using 25 mM siRNA and incubating for 72 h. Knockdown of AAGAB was achieved using an siGENOME SMARTpool (M-0159891), and control knockdown was performed with a non-targeting siRNA (D-001810-10) (both from Thermo-Fisher). Transient transfections with plasmid DNA encoding GFP-tagged protein was achieved using HeLa Monster transfection reagent (Cambridge Bioscience) following the manufacturer's instructions and transfecting 48 h before imaging. For immunofluorescence, cells were grown on glass-bottom coverslips (MatTek), fixed in 3% formaldehyde in PBS at room temperature and permeabilized with 0.1% Triton X-100. Cells were imaged with a Zeiss Axiovert 200 inverted microscope using a Zeiss Plan Achromat 63× oil immersion objective, a Hamamatsu ORCA-ER2 camera and Improvision Openlab software (PerkinElmer).
